BioAffinity Technologies Reports First Quarter 2023 Financia

bioAffinity Technologies, Inc. , a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer and other diseases of the lung, today reported financial results for... | May 15, 2023

Related Keywords

Japan , University Of Texas At San Antonio , Texas , United States , Canada , China , Hong Kong , India , Mexico , Australia , Maria Zannes , Precision Pathology Services , European Union , Affinity Technologies Inc , Havas Health You , Trademark Office , Nasdaq , Trinity Life Sciences , Affinity Technologies , Michael Dougherty , Chief Financial , Havas Health , Nasdaq Stock Market , Compositions Useful , Respiratory Research , Modified Beads , Compensation Controls , Visualized Experiments , Cleveland Clinic , Early Lung Cancer , Affinity President , Chief Executive Officer Maria Zannes , Precision Pathology , Condensed Consolidated Statements , Bioaffinity Technologies , Nc Stock Exchange , News , Information , Press Release , Ioaffinity , Biotechnology , Company , Ddressing , The , Need , Or , Noninvasive , Detection , F , Young , Dancer , End , Mother , Diseases , Oday , Eported , Financial , Esults Biaf Us09076w1099 ,